Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
Cash Flow Performance
Trending higher, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-67.34%
↓ 26% below average
Average (9y)
-53.62%
Historical baseline
Range
High:-13.87%
Low:-116.69%
CAGR
+19.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -67.34% | +24.2% |
| 2023 | -88.89% | -41.1% |
| 2022 | -63.01% | -38.6% |
| 2021 | -45.46% | +20.5% |
| 2020 | -57.19% | +51.0% |
| 2019 | -116.69% | -572.1% |
| 2018 | -17.36% | +56.3% |
| 2017 | -39.76% | -49.1% |
| 2016 | -26.66% | -92.2% |
| 2015 | -13.87% | - |